Related Experiment Video
Updated: May 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Cell based therapy in chronic kidney disease: emerging evidence for a fifth pillar in guideline directed medical
1Department of Nephrology, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India. gerrygeorge007@gmail.com.
Insights
Autologous cell therapy offers a promising regenerative approach for chronic kidney disease (CKD) by potentially rescuing and regenerating lost nephrons. Early trials suggest it may stabilize kidney function decline, offering new hope for CKD patients.
Area of Science:
- Nephrology
- Regenerative Medicine
- Cell Therapy
Background:
- Chronic kidney disease (CKD) affects over 800 million globally, leading to premature cardiovascular mortality.
- Current pharmacological therapies cannot regenerate nephrons lost to damage.
- Autologous renal cell therapy presents a novel approach for nephron regeneration.
Purpose of the Study:
- To review the mechanistic basis, clinical data, and challenges of various autologous cell platforms for CKD.
- To critically evaluate the pros and cons of different cell therapy approaches.
- To discuss a framework for translating cell therapy from procurement to clinical application.
Main Methods:
- Consolidation of mechanistic foundations and clinical trial data for renal cell types.
- Critical evaluation of advantages (immunological compatibility, paracrine effects) and drawbacks (senescence, scalability, regulation).
- Discussion of a procurement pathway-to-clinic framework including bioengineered scaffolds, extracellular vesicles, and kidney-on-a-chip systems.
Main Results:
- Selected renal cells (SRCs), including rilparencel, show potential in stabilizing estimated glomerular filtration rate (eGFR) decline in CKD.
- Autologous cell therapy offers immunological compatibility and paracrine trophic effects.
- Challenges include senescent cell dysfunction, scalability, and regulatory hurdles.
Conclusions:
- Autologous cell therapy is a transformative approach for nephron rescue and regeneration in CKD.
- Further research and development are needed to overcome translational challenges.
- Regenerative medicine holds significant applicability for the future of nephrology.
Abstract:
Chronic kidney disease (CKD) affects over 800 million individuals globally and is a primary aetiology of premature cardiovascular mortality. Despite advancements in pharmacological therapies, these strategies remain incapable of regenerating nephrons lost due to fibrosis, ischemia, or immunological damage. Renal autologous cell therapy, which includes renal tubular epithelial cells, mesenchymal stromal cells, renal progenitor cells, urine-derived stem cells, endothelial progenitor cells, and induced pluripotent stem cell-derived nephron progenitors, signifies a transformative approach towards authentic nephron rescue and regeneration. Preclinical studies and early clinical trials evaluating selected renal cells (SRCs), including rilparencel (REACT®), suggest that autologous renal cell therapy may stabilize estimated glomerular filtration rate (eGFR) decline in diabetic kidney disease and other forms of CKD. This review consolidates the mechanistic foundations, emerging clinical trial data, and translational challenges associated with each principal autologous cell platform utilized in CKD. It critically evaluates the advantages, such as immunological compatibility, paracrine trophic effects, and utility in disease modelling, alongside significant drawbacks, including senescent cell dysfunction, scalability limitations, and regulatory complexities. Furthermore, a procurement pathway -to-in-clinic framework that incorporates bioengineered scaffolds, extracellular vesicle derivatives, CRISPR-corrected iPSC lines, and kidney-on-a-chip validation systems is discussed in this review, collectively delineating the applicability of regenerative medicine in nephrology.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
